Renée Aguiar-Lucander, CEO of Hansa Biopharma, discussed the company’s leading asset, its journey toward US FDA approval and the trials and tribulations of completing a Phase III program.

Hansa Biopharma On Clearing The Path To Kidney Transplant

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

Share Hansa Biopharma On Clearing The Path To Kidney Transplant

Sign up to save your podcasts

Hansa Biopharma On Clearing The Path To Kidney Transplant

Hansa Biopharma On Clearing The Path To Kidney Transplant

More shows like Citeline Podcasts

Marketplace Tech

WSJ Your Money Briefing

WSJ What’s News

Bloomberg Intelligence

HBR IdeaCast

How to Be Awesome at Your Job

GZERO World with Ian Bremmer

The Readout Loud

Thoughts on the Market

The Journal.

The Next Big Idea

BioCentury This Week

Coaching Real Leaders

Biotech Hangout

HBR On Leadership